Merck’s colorectal cancer therapy fails late-stage trial Reuters Sep 26, 2024 Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss
FDA approves Guardant Health’s Shield blood test as first primary CRC screening option EP News Bureau Jul 30, 2024 Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance…
Colorectal cancer market across 8MM to reach $21.8 bn in 2031: GlobalData EP News Bureau Feb 19, 2024 This uptrend is primarily driven by rising diagnosis rates, notably in key markets like the US and China and approvals of 13…
IIT Mandi researchers use natural polymer-based smart nanoparticles to treat colorectal cancer EP News Bureau Aug 30, 2022 Researchers have developed biodegradable nanoparticles from renewable resources which can release both hydrophilic and hydrophobic…